SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-302125
Filing Date
2011-11-08
Accepted
2011-11-08 16:07:41
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d230843d10q.htm 10-Q 495974
2 SECTION 302 CEO CERTIFICATION d230843dex311.htm EX-31.1 9463
3 SECTION 302 CFO CERTIFICATION d230843dex312.htm EX-31.2 9461
4 SECTION 906 CEO CERTIFICATION d230843dex321.htm EX-32.1 4402
5 SECTION 906 CFO CERTIFICATION d230843dex322.htm EX-32.2 4364
  Complete submission text file 0001193125-11-302125.txt   1502596

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achn-20110930.xml EX-101.INS 126375
7 XBRL TAXONOMY EXTENSION SCHEMA achn-20110930.xsd EX-101.SCH 10998
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20110930_cal.xml EX-101.CAL 27721
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20110930_lab.xml EX-101.LAB 101323
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20110930_pre.xml EX-101.PRE 63734
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 111187913
SIC: 2834 Pharmaceutical Preparations